Work

Developing Optimized Treatment Plans for Patients with Dyslipidemia in the Era of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapeutics

Year: 2017

Type: article

Source: The American Journal of Medicine

DOI: 10.1016/j.amjmed.2017.07.004

Authors: James A. Underberg, Michael J. Blaha, Elizabeth J. Jackson, Peter H. Jones

Institutions: NYU Langone Health, Bellevue Hospital Center, New York University, Johns Hopkins University, Johns Hopkins Medicine, St David's Medical Center, Baylor College of Medicine

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2739222438

FWCI:

Cites:

Cited by:

Related to: 10